Sofinnova Investments’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.6M Buy
346,075
+189,274
+121% +$29.1M 2.15% 14
2025
Q4
$27.3M Buy
156,801
+52,462
+50% +$9.57M 1.18% 31
2025
Q3
$15M Sell
104,339
-209,584
-67% -$25.7M 0.82% 36
2025
Q2
$31.6M Buy
313,923
+9,669
+3% +$739K 1.93% 19
2025
Q1
$23.2M Buy
304,254
+47,973
+19% +$3.67M 1.52% 21
2024
Q4
$17.7M Sell
256,281
-30,026
-10% -$2.16M 1.29% 24
2024
Q3
$20.9M Buy
286,307
+58,560
+26% +$4.32M 1.66% 20
2024
Q2
$15.3M Buy
+227,747
New +$8.83M 0.79% 36
2022
Q4
Sell
-220,665
Closed -$4.75M 56
2022
Q3
$4.75M Buy
220,665
+213,295
+2,894% +$5.11M 0.28% 48
2022
Q2
$145K Buy
7,370
+2,002
+37% +$42K 0.01% 58
2022
Q1
$126K Sell
5,368
-436,405
-99% -$10.1M 0.01% 60
2021
Q4
$12M Sell
441,773
-93,347
-17% -$2.67M 0.7% 39
2021
Q3
$14.7M Sell
535,120
-309,049
-37% -$8.11M 0.87% 28
2021
Q2
$24M Buy
844,169
+225,219
+36% +$6.68M 1.38% 17
2021
Q1
$21.1M Buy
618,950
+309,288
+100% +$11.8M 1.27% 23
2020
Q4
$10.3M Sell
309,662
-305,481
-50% -$11.2M 0.61% 34
2020
Q3
$19.8M Buy
615,143
+131,176
+27% +$3.77M 1.47% 16
2020
Q2
$13.3M Buy
+483,967
New +$11.5M 0.84% 28
2019
Q2
Sell
-140,057
Closed -$4.07M 79
2019
Q1
$4.07M Buy
+140,057
New +$3.63M 0.39% 45

Other funds holding INSM

Sofinnova Investments's INSM Position: Q1 2026 in Review

Sofinnova Investments increased its Insmed (INSM) stake by 121% in Q1 2026, buying an estimated $29.1M and bringing the position to 346,075 shares worth $56.6M. The position accounts for 2.15% of the portfolio, ranked #14.

Sofinnova Investments first reported a position in INSM in Q1 2019 and has held it in 19 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Sofinnova Investments held 346,075 shares of Insmed worth $56.6M as of Q1 2026.
  • Sofinnova Investments bought 189,274 Insmed shares in Q1 2026, an estimated $29.1M.
  • Insmed made up 2.15% of Sofinnova Investments's portfolio in Q1 2026, its #14 holding.
  • Sofinnova Investments first reported a position in Insmed in Q1 2019 and has held it in 19 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.